<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>c49745_10-q.htm
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">




<P align="center">
<B><FONT face="serif">FORM 10-Q </FONT></B><B><I><FONT face="serif"> </FONT></I></B><BR>
<B><FONT face="serif">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</FONT></B><FONT face="serif"> </FONT><BR>
<B><FONT face="serif">WASHINGTON, D.C. 20549 </FONT></B></P>
<P align="justify">
<FONT face="serif">(Mark One) </FONT></P>
<TABLE border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">[X]</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT face="serif">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>
<FONT face="serif">SECURITIES EXCHANGE ACT OF 1934</FONT>
  </TD>
</TR>
</TABLE>
<BR>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD width=15% align=left nowrap>
<FONT face="serif">For the quarterly period ended&nbsp;</FONT>
  </TD>
  <TD width=85% align=left nowrap style="border-bottom:1px solid #000000;">
    <div align="center"><FONT face="serif">June 30, 2007</FONT>
    </div></TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT face="serif">OR </FONT></P>
<TABLE border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left width=6% nowrap>
<FONT face="serif">[&nbsp; ]</FONT>
  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
  <TD align=left width=91% nowrap>
<FONT face="serif">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=6% nowrap>&nbsp;

  </TD>
  <TD align=left width=91% nowrap>
<FONT face="serif">SECURITIES EXCHANGE ACT OF 1934</FONT>
  </TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<FONT face="serif">For the transition period from  _______________________________________
to __________</FONT></P>
<TABLE border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left width=68% nowrap>
<FONT face="serif">Commission file number</FONT>
  &nbsp;</TD>
  <TD align=left width=29% nowrap>
<U><FONT face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;001-4802</FONT></U>
  </TD>
</TR>
</TABLE>
<BR>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD align=center style="border-bottom:1px solid #000000;">
<FONT face="serif">Becton, Dickinson and Company</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=center nowrap>
<FONT face="serif">(Exact name of registrant as specified in its charter)</FONT>
  </TD>
</TR>
</TABLE><BR>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD align=left nowrap><div style="border-bottom:1px solid #000000"> &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<font face="serif">New
    Jersey</font> </div></TD>
  <TD width=90%>&nbsp;
  </TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">
<FONT face="serif">22-0760120</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">(State or other jurisdiction of</FONT>
  </TD>
  <TD width=90%>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">(I.R.S. Employer Identification No.)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp;<FONT face="serif">incorporation or organization)</FONT>
  </TD>
  <TD width=90%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
</TABLE><BR>
<P align="center">
<U><FONT face="serif">1 Becton Drive, Franklin Lakes, New Jersey 07417-1880</FONT></U><FONT face="serif"> </FONT><BR>
<FONT face="serif">(Address of principal executive offices) </FONT><BR>
<FONT face="serif">(Zip Code) </FONT><BR>
<BR>
<FONT face="serif"> </FONT><U><FONT face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(201)
847-6800&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></U><BR>
<FONT face="serif">(Registrant's telephone number, including area code) </FONT><BR>
<BR>
<FONT face="serif"> </FONT><U><FONT face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;N/A&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></U><BR>
<FONT face="serif">(Former name, former address and former fiscal year, </FONT><BR>
<FONT face="serif">if changed since last report) </FONT></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="serif">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes </FONT><FONT face="sans-serif">  </FONT><font face=WINGDINGS>x</font><FONT face="serif">&nbsp;No </FONT><font face=WINGDINGS>o</font></P>
<P align="left">
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="serif">Indicate
by checkmark whether the registrant is a large accelerated filer, an accelerated
filer or a non-accelerated filer. See definition of accelerated filer and large
accelerated filer in Rule  12b-2 of the Exchange Act. (Check one): <br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Large accelerated
filer </FONT><font face=WINGDINGS>x</font><FONT face="sans-serif"> </FONT><FONT face="serif"> Accelerated
filer </FONT><font face=WINGDINGS>o</font><FONT face="serif"> Non-accelerated
filer </FONT><font face=WINGDINGS>o</font><FONT face="sans-serif"></FONT></P>
<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="serif">Indicate
    by checkmark whether the registrant is a shell company (as defined in Rule
    12b-2 of the Exchange Act). Yes </FONT><font face=WINGDINGS>o</font><FONT face="serif"> No </FONT><font face=WINGDINGS>x</font><FONT face="sans-serif"> </FONT></P>
<P align="left">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="serif">Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.</FONT></P>
<TABLE width="75%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD align=left nowrap><div style="border-bottom:1px solid #000000"> &nbsp; &nbsp;<font face="serif">Class
    of Common Stock</font> </div></TD>
  <TD width=90%>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
    <div align="center"><FONT face="serif">Shares Outstanding as of June 30, 2007</FONT>
    </div></TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Common stock, par value &#36;1.00</FONT>
  </TD>
  <TD width=90%>&nbsp;
  </TD>
  <TD align=left nowrap> <div align="center"><FONT face="serif">243,388,704</FONT>
  </div></TD>
</TR>
</TABLE><BR>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="center">
<FONT face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT face="serif">FORM 10-Q </FONT><BR>
<FONT face="serif">For the quarterly period ended June 30, 2007 </FONT></P>
<P align="center">
<FONT face="serif">TABLE OF CONTENTS</FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>
<U><FONT face="serif">Part I.</FONT></U>
  </TD>
  <TD width="77%" align=left nowrap>
<U><FONT face="serif">FINANCIAL INFORMATION</FONT></U>
  </TD>
  <TD width="11%">&nbsp;
  </TD>
  <TD width="7%" align=center nowrap>
<U><FONT face="serif">Page Number</FONT></U>
  </TD>
</TR>
<TR>
  <TD colspan=4>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 1.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Financial Statements (Unaudited)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp;<FONT face="serif">Condensed Consolidated Balance Sheets</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">3</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp;<FONT face="serif">Condensed Consolidated Statements of Income</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">4</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp;<FONT face="serif">Condensed Consolidated Statements of Cash Flows</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">5</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp;<FONT face="serif">Notes to Condensed Consolidated Financial Statements</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">6</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 2.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Management&#146;s Discussion and Analysis of Financial Condition</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>
<FONT face="serif">and Results of Operations</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">15</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 3.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Quantitative and Qualitative Disclosures About Market Risk</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">24</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 4.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Controls and Procedures</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">24</FONT>
  </TD>
</TR>
<TR>
  <TD colspan=4>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<U><FONT face="serif">Part II.</FONT></U>
  </TD>
  <TD align=left nowrap>
<U><FONT face="serif">OTHER INFORMATION</FONT></U>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR>
  <TD colspan=4>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 1.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Legal Proceedings</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">25</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 1A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Risk Factors</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">28</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 2.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Unregistered Sales of Equity Securities and Use of</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>
<FONT face="serif">Proceeds</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">28</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 3.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Defaults Upon Senior Securities</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">28</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 4.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Submission of Matters to a Vote of Security Holders</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">28</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 5.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Other Information</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">29</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 6.</FONT>
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Exhibits</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">29</FONT>
  </TD>
</TR>
<TR>
  <TD colspan=4>&nbsp;

  </TD>
</TR>
<TR>
  <TD colspan=4>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Signatures</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">30</FONT>
  </TD>
</TR>
<TR>
  <TD colspan=4>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Exhibits</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap>
<FONT face="serif">31</FONT>
  </TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">2</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="center">
<FONT face="serif">ITEM 1. FINANCIAL STATEMENTS </FONT><BR>
<FONT face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT face="serif">CONDENSED CONSOLIDATED BALANCE SHEETS </FONT><BR>
<FONT face="serif">Thousands of dollars </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD width=90% align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=center nowrap>
<FONT size=2 face="serif">June 30,</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
    <div align="center"><FONT size=2 face="serif">September 30,</FONT>
    </div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<U><FONT size=2 face="serif">Assets</FONT></U>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
    <div align="center"><FONT size=2 face="serif">2007</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
    <div align="center"><FONT size=2 face="serif">2006</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
    <div align="center"><FONT size=2 face="serif">(Unaudited)</FONT>
    </div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Current Assets:</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Cash and equivalents</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">444,164</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,000,289</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Short-term investments</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">132,314</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">106,386</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Trade receivables, net</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,034,047</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">885,748</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Inventories:</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Materials</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">134,814</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">121,598</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Work in process</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">196,836</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">156,957</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Finished products</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">691,698</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">597,183</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,023,348</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">875,738</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Prepaid expenses, deferred taxes and other</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">327,361</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">317,092</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Total Current Assets</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,961,234</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">3,185,253</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR>
  <TD colspan=9>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Property, plant and equipment</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">5,137,003</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">4,742,957</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Less allowances for depreciation and amortization</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2,802,155</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2,609,409</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,334,848</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,133,548</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Goodwill</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">618,761</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">565,146</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Core and Developed Technology, Net</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">370,343</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">244,811</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Other Intangibles, Net</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">80,692</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">91,501</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Capitalized Software, Net</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">155,817</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">189,355</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Other</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">601,150</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">414,911</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Total Assets</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">7,122,845</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">6,824,525</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<U><FONT size=2 face="serif">Liabilities and Shareholders&#146; Equity</FONT></U>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR>
  <TD colspan=9>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Current Liabilities:</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Short-term debt</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">205,772</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">427,218</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Payables and accrued expenses</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,209,008</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,149,111</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Total Current Liabilities</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,414,780</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,576,329</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Long-Term Debt</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">953,112</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">956,971</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Long-Term Employee Benefit Obligations</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">279,104</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">270,495</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Deferred Income Taxes and Other</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">247,954</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">184,526</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Commitments and Contingencies</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=center nowrap>
    <div align="right"><FONT size=2 face="serif">-</FONT>
    </div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=center nowrap>
    <div align="right"><FONT size=2 face="serif">-</FONT>
    </div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Shareholders&#146; Equity:</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Common stock</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">332,662</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">332,662</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Capital in excess of par value</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,070,534</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">873,535</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Retained earnings</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">5,795,744</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">5,345,697</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Deferred compensation</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">11,620</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">11,134</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Common shares in treasury &#150; at cost</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(3,078,117</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(2,698,016</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Accumulated other comprehensive income (loss)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">95,452</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(28,808</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Total Shareholders&#146; Equity</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">4,227,895</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">3,836,204</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR>
  <TD colspan=9>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Total Liabilities and Shareholders&#146; Equity</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">7,122,845</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">6,824,525</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<FONT size=2 face="serif">See notes to condensed consolidated financial statements </FONT></P>
<P align="center">
<FONT size=2 face="serif">3</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="center">
<FONT size=2 face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT size=2 face="serif">CONDENSED CONSOLIDATED STATEMENTS OF INCOME </FONT><BR>
<FONT size=2 face="serif">Thousands of dollars, except per share data </FONT><BR>
<FONT size=2 face="serif">(Unaudited) </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap colspan=5>
    <div align="center"><FONT size=2 face="serif">Three Months Ended</FONT>
    </div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap colspan=5>
    <div align="center"><FONT size=2 face="serif">Nine Months Ended</FONT>
    </div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap colspan=5 style="border-bottom:1px solid #000000;">
    <div align="center"><FONT size=2 face="serif">June 30,</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap colspan=5 style="border-bottom:1px solid #000000;">
    <div align="center"><FONT size=2 face="serif">June 30,</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
    <div align="center"><FONT size=2 face="serif">2007</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
    <div align="center"><FONT size=2 face="serif">2006</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
    <div align="center"><FONT size=2 face="serif">2007</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
    <div align="center"><FONT size=2 face="serif">2006</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Revenues</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,631,159</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,457,347</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,708,607</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,275,401</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Cost of products sold</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">791,071</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">719,515</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,264,544</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,084,227</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Selling and administrative</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">412,164</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">374,565</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,202,879</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,069,914</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Research and development</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">92,993</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">76,699</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">259,620</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">219,473</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Acquired in-process research and development</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">7,394</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">
    <div align="right"><FONT size=2 face="serif">-</FONT>
    </div></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">122,133</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">53,300</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Total Operating Costs and Expenses</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap><div style="border-bottom:1px solid #000000"> <font size=2 face="serif">1,303,622</font> </div></TD>
  <TD align=left nowrap><div style="border-bottom:1px solid #000000">&nbsp;</div>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap><div style="border-bottom:1px solid #000000"> <font size=2 face="serif">1,170,779</font> </div></TD>
  <TD align=left nowrap><div style="border-bottom:1px solid #000000">&nbsp;</div>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap><div style="border-bottom:1px solid #000000"> <font size=2 face="serif">3,849,176</font> </div></TD>
  <TD align=left nowrap><div style="border-bottom:1px solid #000000">&nbsp;</div>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap><div style="border-bottom:1px solid #000000"> <font size=2 face="serif">3,426,914</font> </div></TD>
  <TD align=left nowrap><div style="border-bottom:1px solid #000000">&nbsp;</div>

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Operating Income</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">327,537</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">286,568</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">859,431</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">848,487</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Interest income</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">11,938</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">12,146</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">37,138</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">43,808</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Interest expense</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(11,598</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(15,425</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(36,152</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(51,990</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Other income (expense), net</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,774</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(2,385</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">5,278</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(3,999</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Income From Continuing Operations Before</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=center nowrap>
    <div align="left"><FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income Taxes</FONT>
    </div></TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">329,651</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">280,904</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">865,695</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">836,306</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Income tax provision</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">89,182</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">69,834</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">258,636</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">238,076</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Income From Continuing Operations</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">240,469</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">211,070</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">607,059</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">598,230</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Income (loss) from Discontinued Operations,</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">4,340</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(4,697</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">23,162</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(19,929</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">net</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Net Income</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">244,809</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right valign="middle" nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">206,373</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">630,221</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right valign="middle" nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">578,301</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<U><FONT size=2 face="serif">Basic Earnings per Share:</FONT></U>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>

    <div align="left"></div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>

    <div align="left"></div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Income from Continuing Operations</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">0.98</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">0.86</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2.47</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2.42</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Income (loss) from Discontinued Operations</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">0.02</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>

    <div align="left"></div></TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(0.02</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">0.09</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>

    <div align="left"></div></TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(0.08</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Basic Earnings per Share (A)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">1.00</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right valign="middle" nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">0.84</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">2.57</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right valign="middle" nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">2.34</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<U><FONT size=2 face="serif">Diluted Earnings per Share:</FONT></U>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>

    <div align="left"></div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>

    <div align="left"></div></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Income from Continuing Operations</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">0.95</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">0.83</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2.38</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2.33</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Income (loss) from Discontinued Operations</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">0.02</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>

    <div align="left"></div></TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(0.02</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">0.09</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>

    <div align="left"></div></TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(0.08</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Diluted Earnings per Share (A)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">0.96</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right valign="middle" nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">0.81</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">2.47</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right valign="middle" nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">2.25</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
</TR>
<TR>
  <TD colspan=17>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width="90%" align=left nowrap>
<FONT size=2 face="serif">Dividends per Common Share</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">0.245</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right valign="middle" nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">0.215</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left valign="middle" nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">0.735</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=right valign="middle" nowrap>
    <div align="left"><FONT size=2 face="serif">&#36;</FONT>
    </div></TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">0.645</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<FONT size=2 face="serif">(A) Total per share amounts may not add due to rounding. </FONT></P>
<P align="justify">
<FONT size=2 face="serif">See notes to condensed consolidated financial statements </FONT></P>
<P align="center">
<FONT size=2 face="serif">4</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="center">
<FONT size=2 face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT size=2 face="serif">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </FONT><BR>
<FONT size=2 face="serif">Thousands of dollars </FONT><BR>
<FONT size=2 face="serif">(Unaudited) </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD width=90% align=left nowrap>&nbsp;</TD>
  <TD width=1%>&nbsp;</TD>
  <TD colspan="7" align=center nowrap>
    <FONT size=2 face="serif">Nine Months Ended</FONT></TD>
  </TR>
<TR valign="bottom" bgcolor="#FFFFFF">
  <TD width=90% align=left nowrap>&nbsp;</TD>
  <TD width=1%>&nbsp;</TD>
  <TD colspan="7" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">June 30,</FONT>
  </TD>
  </TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>&nbsp;</TD>
  <TD width=1%>&nbsp;</TD>
  <TD colspan="3" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">2007</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD colspan="3" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">2006</FONT>  </TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<U><FONT size=2 face="serif">Operating Activities</FONT></U>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Net income</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">630,221</FONT></TD>
  <TD align=left nowrap></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">578,301</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">(Income) loss from discontinued operations, net</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(23,162</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">19,929</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Income from continuing operations</FONT>
  </TD>
  <TD width=1%>&nbsp;
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">607,059</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD width="3%">&nbsp;
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">598,230</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Adjustments to income from continuing operations to derive net cash</FONT>
  </TD>
  <TD width=1%>&nbsp;
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD width="3%">&nbsp;
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">provided by continuing operating activities, net of amounts acquired:</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Depreciation and amortization</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">323,565</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">296,207</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Share-based compensation</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">85,220</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">80,664</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Deferred income taxes</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(47,072</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(86,661</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Acquired in-process research and development</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">122,133</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">53,300</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Change in working capital</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(192,632</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(200,243</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Pension obligation</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(40,737</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(85,453</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Other, net</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">17,371</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">26,387</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Net Cash Provided by Continuing Operating Activities</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">874,907</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">682,431</FONT></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
</TR>
<TR>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<U><FONT size=2 face="serif">Investing Activities</FONT></U>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Capital expenditures</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(365,939</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(257,569</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Capitalized software</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(16,075</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(17,240</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Purchases of investments, net</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(10,982</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(13,594</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Acquisitions of businesses, net of cash acquired</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(339,528</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(231,051</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Proceeds from discontinued operations</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">19,971</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=center nowrap>
<FONT size=2 face="serif">-</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Other, net</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(68,385</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(38,634</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Net Cash Used for Continuing Investing Activities</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(780,938</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(558,088</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<U><FONT size=2 face="serif">Financing Activities</FONT></U></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Change in short-term debt</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(122,653</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,042</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Payments of debt</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(100,547</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(617</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Repurchase of common stock</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(412,437</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(432,964</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Issuance of common stock from treasury</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">100,859</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">117,047</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Excess tax benefits from payments under share-based plans</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">43,059</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">42,810</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Dividends paid</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(180,084</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(159,582</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Net Cash Used for Continuing Financing Activities</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(671,803</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(431,264</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<U><FONT size=2 face="serif">Discontinued Operations</FONT></U></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Net cash provided by (used for) operating activities</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">13,829</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(21,041</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Net cash used for investing activities</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">-</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(1,540</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Net Cash Provided by (Used for) Discontinued Operations</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">13,829</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(22,581</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Effect of exchange rate changes on cash and equivalents</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">7,880</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">7,607</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Net decrease in cash and equivalents</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(556,125</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(321,895</FONT></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT></TD>
</TR>
<TR>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Opening Cash and Equivalents</FONT>
  </TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,000,289</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,042,890</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width=90% align=left nowrap>
<FONT size=2 face="serif">Closing Cash and Equivalents</FONT></TD>
  <TD width=1%>&nbsp;</TD>
  <TD width="2%" align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT></TD>
  <TD align=right nowrap  style="border-bottom:3px double #000000">
<FONT size=2 face="serif">444,164</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="3%">&nbsp;</TD>
  <TD width="2%" align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT></TD>
  <TD align=right nowrap  style="border-bottom:3px double #000000">
<FONT size=2 face="serif">720,995</FONT></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<FONT size=2 face="serif">See notes to condensed consolidated financial statements</FONT><FONT face="monospace"> </FONT></P>
<P align="center">
<FONT size=2 face="serif">5</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="center">
<FONT face="serif">BECTON, DICKINSON AND COMPANY </FONT><BR>
<FONT face="serif">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </FONT><BR>
<FONT face="serif">Dollar and share amounts in thousands, except per share data </FONT><BR>
<FONT face="serif">June 30, 2007 </FONT></P>
<P align="justify">
<U><FONT face="serif">Note 1 - Basis of Presentation</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with the instructions to Form 10-Q and, in the opinion of the management of the Company, include all adjustments which are of
a normal recurring nature, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented.  However, the financial statements do not include all information and footnotes required
for a presentation in accordance with U.S. generally accepted accounting principles. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included or
incorporated by reference in the Company's 2006 Annual Report on Form 10-K.  The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for the full year. Certain reclassifications
have been made to prior year amounts to conform to current year presentation.</FONT></P>
<P align="justify">
<U><FONT face="serif">Note 2 &#150; Comprehensive Income</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Comprehensive income was comprised of the following: </FONT></P>
<TABLE width="100%" border=0 cellpadding=0 cellspacing=0>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">Three Months Ended</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">Nine Months Ended</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#FFFFFF">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
  <FONT size=2 face="serif">June 30,</FONT></TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="2%">&nbsp;</TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">June 30,</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="8%" align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="8%" align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="8%" align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD width="8%" align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Net Income</FONT>
  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">244,809</FONT>
  </TD>
  <TD width="1%" align=left nowrap>

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">206,373</FONT>
  </TD>
  <TD width="1%" align=left nowrap>

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">630,221</FONT>
  </TD>
  <TD width="1%" align=left nowrap>

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">578,301</FONT>
  </TD>
  <TD width="1%" align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Other Comprehensive Income (Loss), Net of Tax</FONT>
  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Foreign currency translation adjustments</FONT>
  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">36,438</FONT>
  </TD>
  <TD width="1%" align=left nowrap>

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">54,607</FONT>
  </TD>
  <TD width="1%" align=left nowrap>

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">134,737</FONT>
  </TD>
  <TD width="1%" align=left nowrap>

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">51,688</FONT>
  </TD>
  <TD width="1%" align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Unrealized losses on investments,</FONT>
  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">net of amounts reclassified</FONT>
  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">(595</FONT>
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">(107</FONT>
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">(11,269</FONT>
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap>
<FONT size=2 face="serif">(2,694</FONT>
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Unrealized gains (losses) on cash flow</FONT>
  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">hedges, net of amounts realized</FONT>
  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,945</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(1,486</FONT>
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">792</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(399</FONT>
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=right nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">37,788</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">53,014</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">124,260</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">48,595</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Comprehensive Income</FONT>
  </TD>
  <TD width="1%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">282,597</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">259,387</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">754,481</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD width="8%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">626,896</FONT>
  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<FONT face="serif">The amount of unrealized losses or gains on investments and cash flow hedges in comprehensive income has been adjusted to reflect any realized gains and recognized losses included in net income during the three and nine months
ended June 30, 2007 and 2006. The change in foreign currency translation adjustments is primarily attributable to stronger European currencies versus the U.S. dollar for the nine months ended June 30, 2007, compared with the nine months ended June
30, 2006. </FONT></P>
<P align="center">
<FONT size=2 face="serif">6</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<U><FONT face="serif">Note 3 - Earnings per Share</FONT></U></P>
<P align="justify">
<FONT face="serif">The weighted average common shares used in the computations of basic and diluted earnings per share (shares in thousands) were as follows: </FONT></P>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD colspan="4" align=center nowrap><FONT size=2 face="serif">Three Months Ended</FONT>  </TD>
  <TD align=left>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD colspan="4" align=center nowrap> <FONT size=2 face="serif">Nine Months Ended</FONT>  </TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left width=31% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD colspan="4" align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">June 30,</FONT>
  </TD>
  <TD align=left width=2%>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD colspan="4" align=center nowrap style="border-bottom:1px double #000000;">
<FONT size=2 face="serif">June 30,</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=31% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD align=left width=2%>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD align=left width=2%>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD align=left width=2%>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left width=31% nowrap>
<FONT size=2 face="serif">Average common shares outstanding</FONT>
  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">244,918</FONT>
  </TD>
  <TD align=left width=2% nowrap>

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">246,633</FONT>
  </TD>
  <TD align=left width=2% nowrap>

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">245,296</FONT>
  </TD>
  <TD align=left width=2% nowrap>

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">247,588</FONT>
  </TD>
  <TD align=left width=2% nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=31% nowrap>
<FONT size=2 face="serif">Dilutive share equivalents from</FONT>
  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left width=31% nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">share-based plans</FONT>
  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">9,210</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">8,437</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">9,833</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">8,912</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=31% nowrap>
<FONT size=2 face="serif">Average common and common</FONT>
  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left width=31% nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">equivalent shares outstanding &#150;</FONT>
  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left width=2% nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=31% nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">assuming dilution</FONT>
  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">254,128</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">255,070</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">255,129</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">256,500</FONT>
  </TD>
  <TD align=left width=2% nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<U><FONT face="serif">Note 4 - Contingencies</FONT></U></P>
<P align="justify">
<FONT face="serif">The Company is involved, both as a plaintiff and a defendant, in various legal proceedings and claims which arise in the ordinary course of business as set forth in the Company&#146;s 2006 Annual Report on Form 10-K. The following
discussion represents new matters that have occurred in 2007 and any recent developments related to previously described matters.</FONT></P>
<P align="justify">
<U><FONT face="serif">Retractable Technologies, Inc.</FONT></U></P>
<P align="justify">
<FONT face="serif">As was previously reported, in June 2007, Retractable Technologies, Inc. (&#147;plaintiff&#148;) filed a complaint against the Company under the caption </FONT><U><FONT face="serif">Retractable Technologies, Inc. vs. Becton
Dickinson and Company</FONT></U><FONT face="serif"> (Civil Action No. 2:07-cv-250, United States District Court, Eastern District of Texas).  Plaintiff alleges that BD Integra&#153; syringes infringe patents licensed exclusively to the plaintiff.
This patent claim was not covered by the release contained in the July 2004 settlement agreement between the Company and plaintiff to settle the lawsuit previously filed by plaintiff. </FONT></P>
<P align="justify">
<FONT face="serif">In its complaint, plaintiff also alleges that the Company engaged in false advertising with respect to certain of the Company&#146;s safety-engineered products in violation of the Lanham Act; acted to exclude the plaintiff from
various product markets and to maintain its market share through, among other things, exclusionary contracts in violation of state and Federal antitrust laws; and engaged in unfair competition. The non-patent claims purport to relate to actions
allegedly taken by the Company following the date of the July 2004 settlement agreement referenced above. </FONT></P>
<P align="justify">
<FONT face="serif">Plaintiff seeks treble damages, attorney&#146;s fees and injunctive relief. The Company believes it has meritorious defenses to these claims and intends to vigorously defend this lawsuit. </FONT></P>
<P align="justify">
<U><FONT face="serif">Antitrust Class Action Suits</FONT></U></P>
<P align="justify">
<FONT face="serif">Two additional purported class action antitrust cases have been filed against the Company, as follows:</FONT></P>
<P align="center">
<FONT size=2 face="serif">7</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<UL>
<LI>
<P align="justify"><U><FONT face="serif">The Hebrew Home for the Aged at Riverdale v. Becton Dickinson and Company</FONT></U> <FONT face="serif">was filed on March 28, 2007 in federal court in the Southern District of New York (Case No. 07-CV-2544).</FONT></P>
</LI>

<LI>
<P align="justify"><U><FONT face="serif">International Multiple Sclerosis Management Practice v. Becton Dickinson &amp; Company</FONT></U> <FONT face="serif">was filed on April 5, 2007 in federal court in the District of New Jersey (Case No.
2:07- cv-10602).</FONT></P></LI>
</UL>
<P align="justify">
<FONT face="serif">These purported class action cases have been brought on behalf of alleged indirect purchasers of the Company&#146;s products. In each case, the plaintiff seeks treble damages, attorney&#146;s fees and injunctive relief. Including
the above actions, 10 purported antitrust class action lawsuits have been brought against the Company by direct and indirect purchasers of the Company&#146;s products. These two new antitrust class action lawsuits were consolidated for pre-trial
purposes with the other eight actions in the Multi-District Litigation currently pending in federal court in New Jersey. As directed by the court, the direct and indirect purchaser plaintiffs in the Multi-District Litigation have filed consolidated
complaints with the court. The Company&#146;s motions to dismiss the consolidated complaints filed by each of the direct and indirect purchaser plaintiffs were denied by the court. Class certification motions in these actions are scheduled to be
filed by the end of 2007. </FONT></P>
<P align="justify">
<U><FONT face="serif">bioM&eacute;rieux</FONT></U></P>
<P align="justify">
<FONT face="serif">In April 2007, bioM&eacute;rieux SA initiated an arbitration
proceeding with the International Chamber of Commerce International Court of
Arbitration in Paris, France, against GeneOhm Sciences Canada (&#147;GeneOhm&#148;),
a  subsidiary of the Company. The arbitration related to a sublicense agreement
under which bioM&eacute;rieux granted certain patent rights to GeneOhm relating
to a method for the detection of methicillin-resistant </FONT><I><FONT face="serif">Staphylococcus
aureus</FONT></I><FONT face="serif"> (&#147;MRSA&#148;).  In the arbitration,
bioM&eacute;rieux alleged, among other things, that GeneOhm fraudulently induced
bioM&eacute;rieux into entering into the sublicense and
assigned its rights in violation of the sublicense. In the arbitration, bioM&eacute;rieux
sought monetary damages and to terminate the patent rights granted to GeneOhm
under the sublicense agreement.</FONT></P>
<P align="justify"><font face="serif">The Company and bioM&eacute;rieux subsequently
    entered into an agreement to settle the arbitration proceeding. The financial
    terms of the settlement will not have any material impact on the Company. </font></P>
<P align="center">
<FONT size=2 face="serif">8</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<U><FONT face="serif">Oil-For-Food Programme</FONT></U></P>
<P align="justify">
<FONT face="serif">As was previously reported, Becton Dickinson France, S.A., a subsidiary of the Company, was listed among approximately 2,200 other companies in an October 2005 report of the Independent Inquiry Committee (&#147;IIC&#148;) of the
United Nations (&#147;UN&#148;) as having been involved in humanitarian contracts in which unauthorized payments were suspected of having been made to the Iraqi Government in connection with the UN&#146;s Oil-for-Food Programme (the
&#147;Programme&#148;). The Company conducted an internal review and found no evidence that it or any of its employees or representatives made, authorized, or approved improper payments to the Iraqi Government in connection with the Programme. The
Company reported the results of its internal review to the Vendor Review Committee of the United Nations Procurement Service.  In May 2007, the French Judicial Police conducted searches of the Company&#146;s offices in France with respect to the
matters that were the subject of the 2005 IIC report. The Company was informed that it is one of a number of companies named in the IIC report that is being investigated by the French Judicial Police. The Company is cooperating fully with the
investigation. </FONT></P>
<P align="justify">
<U><FONT face="serif">El Seif Development</FONT></U></P>
<P align="justify">
<FONT face="serif">In July 2007, the Company received notice of a suit instituted
in Saudi Arabia by El Seif Development (&#147;El Seif&#148;),
a former distributor (Case No. 7516, Board of Grievances, Saudi Arabia). El Seif
seeks monetary damages arising out of the termination of its distributor agreement
and other contractual arrangements with the Company. The Company believes that
it has meritorious defenses to these claims and intends to vigorously defend
this lawsuit. </FONT></P>
<P align="justify">
<U><FONT face="serif">Other</FONT></U></P>
<P align="justify">
<FONT face="serif">As was previously reported, in August 2004, the Company was served with an administrative subpoena issued by the United States Attorney&#146;s Office in Dallas, Texas (the &#147;U.S. Attorney&#148;) in connection with an
investigation the U.S. Attorney is conducting of transactions between another company and certain of its suppliers, including the Company. The Company has fully responded to the subpoena.  Recently, the U.S. Attorney requested that the Company
inform the U.S. Attorney as to the availability of a small number of the Company&#146;s employees for interviews. The Company was advised that the U.S. Attorney was making similar requests of other suppliers who had dealings with the company.
</FONT></P>
<P align="justify">
<FONT face="serif">As previously reported, the Company has received a subpoena issued by the Connecticut Attorney General and a subpoena issued by the Illinois Attorney General, each seeking documents and information relating to the Company&#146;s
participation as a member of Healthcare Research &amp; Development Institute, LLC (&#147;HRDI&#148;), a healthcare trade organization. In January 2007, it was reported that HRDI entered into a settlement with the Attorneys General of Connecticut and
Florida with respect to the investigation being conducted by the Connecticut Attorney General, although the Connecticut Attorney General is still investigating certain corporate members of HRDI. The investigation by the Illinois Attorney General is
ongoing. The Company believes that its participation in HRDI complied fully with the law and has responded to these subpoenas. The Company has not received any communication with respect to either investigation since completing its document
production. </FONT></P>
<P align="center">
<FONT size=2 face="serif">9</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">Given the uncertain nature of litigation generally, the Company is not able in all cases to estimate the amount or range of loss that could result from an unfavorable outcome of the litigation to which it is a party.  In
accordance with U.S. generally accepted accounting principles, the Company establishes accruals to the extent probable future losses are estimable (in the case of environmental matters, without considering possible third-party recoveries). In view
of the uncertainties of litigation, the Company could incur charges in excess of any currently established accruals and, to the extent available, excess liability insurance.  In the opinion of management, any such future charges, individually or in
the aggregate, could have a material adverse effect on the Company&#146;s consolidated results of operations and consolidated net cash flows in the period or periods in which they are recorded or paid.</FONT></P>
<P align="justify">
<U><FONT face="serif">Note 5 &#150; Segment Data</FONT></U></P>
<P align="justify">
<FONT face="serif">The Company&#146;s organizational structure is based upon its three principal business segments: BD Medical (&#147;Medical&#148;), BD Diagnostics (&#147;Diagnostics&#148;), and BD Biosciences (&#147;Biosciences&#148;). The Company
evaluates segment performance based upon operating income. Segment operating income represents revenues reduced by product costs and operating expenses.  Financial information for the Company&#146;s segments was as follows: </FONT></P>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD colspan="6" align=center nowrap><FONT size=2 face="serif">Three
    Months Ended</FONT> </TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD colspan="6" align=center nowrap><FONT size=2 face="serif">Nine
    Months Ended</FONT> </TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD colspan="6" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">June
    30,</FONT> </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD colspan="6" align=center nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">June
    30,</FONT> </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
</TR>
<TR align="center" valign="bottom">
  <TD nowrap>&nbsp;

  </TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="10%" nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="2%" nowrap>&nbsp;

  </TD>
  <TD width="2%" nowrap>&nbsp;</TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="10%" nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD nowrap>&nbsp;

  </TD>
  <TD nowrap>&nbsp;</TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="10%" nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="2%" nowrap>&nbsp;

  </TD>
  <TD width="2%" nowrap>&nbsp;</TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="10%" nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD nowrap style="border-bottom:1px solid #000000;">&nbsp;</TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<U><FONT size=2 face="serif">Revenues </FONT></U><FONT size=2 face="serif">(A)</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Medical</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">881,986</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">802,118</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,552,376</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">2,322,831</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Diagnostics</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">491,525</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">426,939</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,407,156</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,286,225</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Biosciences</FONT>
  </TD>
  <TD align=left  nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">257,648</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left  nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">228,290</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=right  nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">749,075</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">666,345</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right  nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right  nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,631,159</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,457,347</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=right  nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right  nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">4,708,607</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
  <TD align=right  nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right  nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">4,275,401</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap></TD>
</TR>
</TABLE>
<BR>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap>
<U><FONT size=2 face="serif">Segment Operating Income</FONT></U>
  </TD>
  <TD width=1% align=left nowrap>&nbsp;

  </TD>
  <TD width="10%" align=left nowrap>&nbsp;

  </TD>
  <TD width=2% align=left nowrap>&nbsp;

  </TD>
  <TD width=2% align=left nowrap>&nbsp;

  </TD>
  <TD width=1% align=left nowrap>&nbsp;

  </TD>
  <TD width="10%" align=left nowrap>&nbsp;

  </TD>
  <TD width=2% align=left nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD width=1% align=left nowrap>&nbsp;

  </TD>
  <TD width="10%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD width="1%" align=left nowrap>&nbsp;

  </TD>
  <TD width="10%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%" align=left nowrap>&nbsp;</TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Medical</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">247,275</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">212,101</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">727,549</FONT>
  </TD>
  <TD align=left nowrap></TD>
  <TD align=left nowrap></TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">641,765</FONT>
  </TD>
  <TD align=left nowrap></TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Diagnostics</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">115,322</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">104,296</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">224,351</FONT>
  </TD>
  <TD align=left nowrap><FONT size=2 face="serif">(B)</FONT>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;   </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">281,392</FONT>
  </TD>
  <TD align=left nowrap><FONT size=2 face="serif">(C)</FONT></TD>
  <TD align=left nowrap>
<FONT color="#ff0000" size=2 face="serif">&nbsp; </FONT>
  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Biosciences</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">58,543</FONT>
  </TD>
  <TD align=left nowrap><FONT size=2 face="serif">(B)</FONT>

  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">52,295</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">182,688</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">157,516</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Total Segment Operating Income</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">421,140</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">368,692</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,134,588</FONT>
  </TD>
  <TD align=left nowrap></TD>
  <TD align=left nowrap></TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,080,673</FONT>
  </TD>
  <TD align=left nowrap></TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Unallocated Items (D)</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(91,489</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(87,788</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(268,893</FONT>
  </TD>
  <TD align=left nowrap><FONT size=2 face="serif">)</FONT> </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(244,367</FONT>
  </TD>
  <TD align=left nowrap><font size=2 face="serif">)</font></TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Income from Continuing</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">Operations Before Income Taxes</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">329,651</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">280,904</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif" style="border-bottom:1px solid #000000;">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">865,695</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">836,306</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
</TABLE>
<BR>
<TABLE border=0 cellspacing=0 cellpadding=0>
<TR>
  <TD nowrap valign=top>
<I><FONT size=2 face="serif">(A)</FONT></I></TD>
  <TD width=100%>
<P align="justify"><I><FONT size=2 face="serif">Intersegment revenues are not material.</FONT></I></P>
  </TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
  <TD nowrap valign=top>
<I><FONT size=2 face="serif">(B)</FONT></I></TD>
  <TD width=100%>
<P align="justify"><I><FONT size=2 face="serif">Includes the acquired in-process research and development charges recorded in the third and first quarter of 2007 related to the Plasso and TriPath acquisitions, respectively. See Note 8 for additional
information.</FONT></I></P>
  </TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
  <TD nowrap valign=top>
<I><FONT size=2 face="serif">(C)</FONT></I></TD>
  <TD width=100%>
<P align="justify"><I><FONT size=2 face="serif">Includes the acquired in-process research and development charge related to the GeneOhm acquisition.</FONT></I></P>
  </TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR><TR>
  <TD nowrap valign=top>
<I><FONT size=2 face="serif">(D)</FONT></I></TD>
  <TD width=100%>
<P align="justify"><I><FONT size=2 face="serif">Includes primarily share-based compensation expense; interest, net; foreign exchange; corporate expenses; and proceeds from insurance settlements received in 2006 in connection with the Company&#146;s
previously owned latex glove business.</FONT></I></P>
  </TD>
</TR>
<TR><TD colspan=2>&nbsp;</TD></TR></TABLE>
<P align="center">
<FONT size=2 face="serif">10</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD colspan="5" align=center nowrap>
    <FONT size=2 face="serif">Three Months Ended</FONT>
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD colspan="5" align=center nowrap>
    <FONT size=2 face="serif">Nine Months Ended</FONT>
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">June 30,</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">June 30,</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR align="center" valign="bottom">
  <TD nowrap>&nbsp;

  </TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="10%" nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="2%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="10%" nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD nowrap>&nbsp;

  </TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="10%" nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="2%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="1%" align="right">&nbsp;
  </TD>
  <TD width="10%" nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<U><FONT size=2 face="serif">Revenues by Organizational Units</FONT></U>
  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align="right">&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<U><FONT size=2 face="serif">BD Medical</FONT></U>
  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align="right">&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Medical Surgical Systems</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">472,195</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">448,116</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,387,286</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap><FONT size=2 face="serif">&#36;</FONT> </TD>
  <TD align=right nowrap><FONT size=2 face="serif">1,300,859</FONT> </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Diabetes Care</FONT>
  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">174,870</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">163,741</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">514,746</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align="right">&nbsp;
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">490,407</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Pharmaceutical Systems</FONT>
  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">216,749</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">174,080</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">598,501</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align="right">&nbsp;
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">484,952</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Ophthalmic Systems</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">18,172</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">16,181</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">51,843</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align="right" nowrap style="border-bottom:1px solid #000000;">&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">46,613</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">881,986</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">802,118</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2,552,376</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&#36;</FONT> </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
  <FONT size=2 face="serif">2,322,831</FONT> </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align="right">&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<U><FONT size=2 face="serif">BD Diagnostics</FONT></U>
  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align="right">&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Preanalytical Systems</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">261,333</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">239,498</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">746,152</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align="right"><FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">688,523</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Diagnostic Systems</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">230,192</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">187,441</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">661,004</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align="right" nowrap style="border-bottom:1px solid #000000;">&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">597,702</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">491,525</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">426,939</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,407,156</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&#36;</FONT> </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
  <FONT size=2 face="serif">1,286,225</FONT> </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<U><FONT size=2 face="serif">BD Biosciences</FONT></U>
  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align="right">&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Immunocytometry Systems</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">144,565</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">123,974</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">418,766</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align="right"><FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">360,400</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Pharmingen</FONT>
  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">42,615</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">39,295</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">125,617</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align="right">&nbsp;
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">117,838</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp;<FONT size=2 face="serif">Discovery Labware</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">70,468</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">65,021</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">204,692</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align="right" nowrap style="border-bottom:1px solid #000000;">&nbsp;
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">188,107</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">257,648</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">228,290</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">749,075</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align="right" nowrap style="border-bottom:1px solid #000000;">
  <FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">666,345</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align="right">&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,631,159</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,457,347</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">4,708,607</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">&#36;</FONT> </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif">4,275,401</FONT> </TD>
  <TD align=left nowrap>

  </TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<U><FONT face="serif">Note 6 &#150; Share-Based Compensation</FONT></U></P>
<P align="justify">
<FONT face="serif">The Company grants share-based awards under the 2004 Employee and Director Equity-Based Compensation Plan (the &#147;2004 Plan&#148;), which provide for long-term incentive compensation to employees and directors. The Company
believes such awards align the interests of its employees and directors with those of its shareholders.</FONT></P>
<P align="justify">
<FONT face="serif">The fair value of share-based payments is recognized as compensation expense in net income. For the three months ended June 30, 2007 and 2006, compensation expense charged to income was &#36;24,560 and &#36;22,217, respectively.
For the nine months ended June 30, 2007 and 2006, compensation expense was &#36;85,220 and &#36;80,664, respectively. </FONT></P>
<P align="justify">
<FONT face="serif">The amount of unrecognized compensation expense for all non-vested share-based awards as of June 30, 2007 was approximately &#36;134,498, which is expected to be recognized over a weighted-average remaining life of approximately
2.1 years. </FONT></P>
<P align="justify">
<FONT face="serif">The fair values of stock appreciation rights granted during the annual share-based grants in November of 2006 and 2005, respectively, were estimated on the date of grant using a lattice-based binomial valuation model based on the
following assumptions: risk-free interest rates of 4.56% and 4.48%, respectively; expected volatility of 28% for both periods; expected dividend yield of 1.37% and 1.46%, respectively; and expected life of 6.5 years for both periods.</FONT><B><FONT face="serif"> </FONT></B></P>
<P align="center">
<FONT size=2 face="serif">11</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<U><FONT face="serif">Note 7 &#150; Benefit Plans</FONT></U></P>
<P align="justify">
<FONT face="serif">The Company has defined benefit pension plans covering substantially all of its employees in the United States and certain foreign locations. The Company also provides certain postretirement healthcare and life insurance benefits
to qualifying domestic retirees.  Other postretirement benefit plans in foreign countries are not material.</FONT></P>
<P align="justify">
<FONT face="serif">Net pension and postretirement cost included the following components for the three months ended June 30: </FONT></P>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">Pension Plans</FONT>
  </TD>
  <TD width="2%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">Other Postretirement Benefits</FONT>
  </TD>
  <TD width="2%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="13%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="4%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="13%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="13%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="4%" align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width="13%" align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Service cost</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">17,366</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">18,004</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">771</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">1,017</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Interest cost</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">19,026</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">17,443</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">3,353</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">3,716</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Expected return on plan assets</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(22,279</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(19,385</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#151;</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#151;</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Amortization of prior service cost</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">49</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">47</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(1,818</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(1,558</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Amortization of loss</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">4,340</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">6,745</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2,051</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,769</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">18,502</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">22,854</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">4,357</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">

  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000;">
<FONT size=2 face="serif">4,944</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<FONT face="serif">Net pension and postretirement cost included the following components for the nine months ended June 30: </FONT></P>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">Pension Plans</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD colspan="5" align=center nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">Other Postretirement Benefits</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR align="center" valign="bottom">
  <TD nowrap>&nbsp;

  </TD>
  <TD width=1% nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width=13% nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width=4% nowrap>&nbsp;

  </TD>
  <TD width=1% nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width=13% nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD width=2% nowrap>&nbsp;

  </TD>
  <TD width=1% nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width=13% nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width=4% nowrap>&nbsp;

  </TD>
  <TD width=1% nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD width=13% nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD width="2%" nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Service cost</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">48,732</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">54,498</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">3,272</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">3,051</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Interest cost</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">53,390</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">52,798</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">10,980</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">11,148</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Expected return on plan assets</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(62,516</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(58,678</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#151;</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">&#151;</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Amortization of prior service cost</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">136</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">142</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(4,599</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(4,674</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Amortization of loss</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">12,177</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">20,417</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">4,378</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">5,307</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
</TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">51,919</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">69,177</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">14,031</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">14,832</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
</TR>
</TABLE>
<BR>
<P align="justify">
<U><FONT face="serif">Note 8 &#150; Acquisitions and Divestiture</FONT></U></P>
<P align="justify">
<I><FONT face="serif"></FONT></I><I><FONT face="serif">TriPath</FONT></I></P>
<P align="justify">
<FONT face="serif">On December 20, 2006, the Company acquired the outstanding shares (approximately 93.8%) of TriPath Imaging, Inc. (&#147;TriPath&#148;) which it did not previously own.  TriPath develops, manufactures, markets and sells innovative
solutions to improve the clinical management of cancer, including detection, diagnosis, staging and treatment.  The acquisition advances the Company&#146;s position in cancer diagnostics.  The acquisition was accounted for as a business combination
and the results of operations of TriPath were included in the Diagnostics Segment&#146;s results as of the acquisition date. Pro forma information was not provided as the acquisition did not have a material effect on the Company&#146;s consolidated
results.  The purchase price was &#36;361,883 in cash, including transaction costs and other consideration. The purchase price was allocated based upon the fair values of the assets and liabilities acquired. The allocation of the purchase price
resulted in deferred tax assets of &#36;74,221 primarily consisting of net operating loss carry-forwards and credits; core and developed technology of &#36;135,097; deferred tax</FONT></P>
<P align="center">
<FONT size=2 face="serif">12</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">liabilities of &#36;52,662 primarily associated with other intangible assets; and other net assets of &#36;51,857 consisting primarily of cash and trade receivables. Core and developed technology will be amortized on a
straight-line basis over its estimated useful life of approximately 15 years. The excess of the purchase price over the fair value of the assets acquired of &#36;38,631 was recorded as goodwill.</FONT></P>
<P align="justify">
<FONT face="serif">In connection with the acquisition, the Company also incurred a non-deductible charge of &#36;114,739 for acquired in-process research and development. This charge, based on fair value, is associated with three projects: molecular
Pap test, breast staging, and ovarian cancer detection. These projects had not yet reached technological feasibility and did not have alternative future use at the acquisition date. The portion of the charge allocated to each of these projects was
&#36;75,992, &#36;18,764 and &#36;19,983, respectively.</FONT></P>
<P align="justify">
<FONT face="serif">The molecular Pap test uses proprietary molecular biomarkers and reagents that are intended to allow for the primary screening of cervical cancer. The diagnostic assay is being developed to test slides prepared using
TriPath&#146;s SurePath&#174; liquid-based Pap test and to permit concurrent evaluation of morphologic features and measurement of the over-expression of molecular biomarkers that are associated with biopsy-proven moderate to severe cervical disease
and cancer. Clinical trials have been initiated for this project. </FONT></P>
<P align="justify">
<FONT face="serif">The breast staging project uses proprietary molecular biomarkers and reagents that are intended to predict the risk of disease recurrence and to aid in treatment selection in patients with early stage breast cancer.  The
diagnostic assay is being developed for use with commercially available detection kits and staining platforms and will utilize TriPath&#146;s interactive histology imaging system to quantify biomarker over-expression in tissue samples collected at
the time of initial diagnosis of breast cancer. Clinical trials have been initiated for this project. </FONT></P>
<P align="justify">
<FONT face="serif">The ovarian cancer detection project is intended to allow for serum-based screening and monitoring assays for ovarian cancer based upon the detection of multiple biomarkers using a proprietary panel of biomarkers and assay
algorithms. In addition, multiplex testing platforms are being evaluated to allow for the simultaneous testing of multiple markers from a small volume of serum. The detection assays being developed will utilize certain technologies from the
Biosciences segment. Clinical trials have not been initiated for this project. </FONT></P>
<P align="justify">
<FONT face="serif">The fair values of these projects were determined based upon the present value of projected cash flows utilizing an income approach reflecting the appropriate risk-adjusted discount rate based on the applicable technological and
commercial risk of each project. These cash flows also took into account the income and expenses associated with the further development and commercialization of the underlying products.  The range of discount rates assigned to the projects was 22
to 30 percent and gave consideration to the underlying risk relative to the developed technology, the overall commercial and technical risk, and the probabilities of success for each of the projects.  The ongoing activity associated with each of
these projects is not expected to be material to the Company&#146;s Research and development expense. </FONT></P>
<P align="justify">
<I><FONT face="serif">Other </FONT></I></P>
<P align="justify">
<FONT face="serif">On May 4, 2007, the Company acquired all of the outstanding shares of Plasso Technology, Ltd. (&#147;Plasso&#148;), a privately-held company that is developing the next generation of surface-critical research tools utilizing
functional coating technology for applications in glycomics and cell</FONT></P>
<P align="center">
<FONT size=2 face="serif">13</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">culture, for &#36;10,425 in cash including transaction costs. In connection with the acquisition, the Company incurred a non-deductible charge of &#36;7,394 for acquired in-process research and development associated with
Plasso&#146;s technology, for which, at the acquisition date, technological feasibility had not been established and no alternative future use existed. Because Plasso was a development stage company that had not commenced its planned principal
operations, the transaction was accounted for as an acquisition of assets rather than as a business combination and, therefore, goodwill was not recorded.</FONT></P>
<P align="justify">
<I><FONT face="serif"></FONT></I><I><FONT face="serif">Divestiture</FONT></I></P>
<P align="justify">
<FONT face="serif">On September 28, 2006, the Company announced a plan to exit the blood glucose monitoring (&#147;BGM&#148;) market. The decision to exit the BGM market was made following an evaluation of the future outlook for the product line.
The Company recorded a pre-tax charge of &#36;63,414, which was included in the Medical segment, in connection with its decision to exit the BGM product line.  At September 30, 2006, an accrual of &#36;32,408, which primarily consisted of
inventory-related purchase commitments and severance, was reported in current liabilities. At June 30, 2007, the remaining accrual was &#36;2,694, after reflecting the reversal of &#36;4,160 of these costs, including &#36;972 reversed during the
second quarter of 2007. </FONT></P>
<P align="justify">
<FONT face="serif">During the first quarter of 2007, the Company received an unsolicited offer for the purchase of the BGM product line. On December 11, 2006, the Company sold the product line for &#36;19,971 and recognized a pre-tax gain on sale of
&#36;15,226.  During the second quarter of 2007, the Company recognized adjustments, thereby increasing the gain on sale by &#36;6,093.  These adjustments constitute revisions to estimated sales return accruals, primarily related to obligations that
ceased to exist in the second quarter pursuant to the sale terms.  During the second and third quarters of 2007, net adjustments of &#36;2,236 and &#36;395, respectively, were made to reduce other accruals related to obligations that remained with
the Company upon divestiture of the product line.  Additionally, during the third quarter of 2007, the Company received a payment of &#36;4,675, which represented the resolution of a contingency with a former supplier. Following the sale, the
Company&#146;s prior period Condensed Consolidated Statements of Income and Cash Flows and related disclosures have been restated to separately present the results of the BGM product line as discontinued operations. The September 30, 2006 Condensed
Consolidated Balance Sheet has not been restated.</FONT></P>
<P align="justify">
<FONT face="serif">Results of discontinued operations were as follows: </FONT></P>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD width="1%" align=right nowrap>&nbsp;</TD>
  <TD colspan="6" align=center nowrap>
    <FONT size=2 face="serif">Three Months Ended</FONT>
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD colspan="6" align=center nowrap>
    <FONT size=2 face="serif">Nine Months Ended</FONT>
  </TD>
  <TD width="2%" align=left nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  </TR>
<TR align="center" valign="bottom">
  <TD nowrap>&nbsp;

  </TD>
  <TD nowrap>&nbsp;</TD>
  <TD colspan="6" nowrap style="border-bottom:1px solid #000000;">
   <FONT size=2 face="serif">June
      30,</FONT>
  </TD>
  <TD nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD colspan="6" nowrap style="border-bottom:1px solid #000000;">
    <FONT size=2 face="serif">June 30,</FONT>
  </TD>
  <TD nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  </TR>
<TR align="center" valign="bottom">
  <TD nowrap>&nbsp;

  </TD>
  <TD nowrap>&nbsp;</TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="2%" nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2007</FONT>
  </TD>
  <TD width="2%" nowrap>&nbsp;

  </TD>
  <TD width="2%">&nbsp;
  </TD>
  <TD width="1%" nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2006</FONT>
  </TD>
  <TD nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD>&nbsp;</TD>
  <TD align=center nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;"></TD>
  <TD>&nbsp;</TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Revenues</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">4,087</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
 <FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">26,351</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">26,938</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">71,675</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD>&nbsp;
  </TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Income (loss) from discontinued operations</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD>&nbsp;
  </TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
 &nbsp; &nbsp; &nbsp;<FONT size=2 face="serif">before income taxes</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">7,044</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(7,562</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">37,228</FONT>
  </TD>
  <TD align=left nowrap>

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD align=right nowrap>
<FONT size=2 face="serif">(32,056</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD><FONT size=2 face="serif">(A)</FONT>
  </TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT size=2 face="serif">Income tax (provision) benefit</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(2,704</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2,865</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">(14,066</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">&nbsp;

  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">12,127</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">

  </TD>
  <TD>&nbsp;
  </TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap>
<FONT size=2 face="serif">Income (loss) from discontinued operations, net</FONT>
  </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">4,340</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
 <FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">(4,697</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">23,162</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:3px double #000000">

  </TD>
  <TD>&nbsp;
  </TD>
  <TD align=center nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">&#36;</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:3px double #000000">
<FONT size=2 face="serif">(19,929</FONT>
  </TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">)</FONT>
  </TD>
  <TD>&nbsp;
  </TD>
  </TR>
</TABLE>
<BR>
<P align="justify">
<FONT size=2 face="serif">(A) Includes a post-closing adjustment related to the divestiture of Clontech of &#36;3,500 (&#36;2,170 after taxes).</FONT><FONT face="serif"> </FONT></P>
<P align="center">
<FONT size=2 face="serif">14</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">Item 2. </FONT><U><FONT face="serif">Management's Discussion and Analysis of Financial Condition and Results of Operations</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<U><FONT face="serif">Company Overview</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Becton, Dickinson and Company (&#147;BD&#148; or the &#147;Company&#148;) is a medical technology company engaged principally in the manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and
diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public. Our business consists of three worldwide business segments &#150; BD Medical (&#147;Medical&#148;), BD Diagnostics
(&#147;Diagnostics&#148;) and BD Biosciences (&#147;Biosciences&#148;). Our products are marketed in the United States and internationally through independent distribution channels, directly to end-users and by independent sales
representatives.</FONT></P>
<P align="justify">
<U><FONT face="serif">Financial Results</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">BD reported third quarter revenues of &#36;1.631 billion, an increase of 12% from the same period a year ago, and reflected volume increases of approximately 9% and favorable foreign currency translation of approximately 3%. Sales
in the United States of safety-engineered devices grew 5% to &#36;246 million in the third quarter of 2007, compared with the prior year&#146;s period. International sales of safety-engineered devices grew 29% to &#36;108 million in the third
quarter of 2007, compared with the prior year&#146;s period. Overall, international revenue growth of 13% for the three-month period included a 6% favorable impact of foreign currency translation. As further discussed in our 2006 Annual Report on
Form 10-K, we face currency exposure that arises from translating the results of our worldwide operations to the U.S. dollar at exchange rates that fluctuate from the beginning of the period.  We purchase option and forward contracts to partially
protect against adverse foreign exchange rate movements. </FONT></P>
<P align="justify">
<FONT face="serif">Our balance sheet remains strong, with net cash provided by continuing operations at approximately &#36;875 million for the nine months ended June 30, 2007, and our debt-to-capitalization ratio decreasing to 20.7% at June 30, 2007
from 25.8% at September 30, 2006.</FONT></P>
<P align="justify">
<U><FONT face="serif">Recent Developments</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">On December 20, 2006, we acquired the 93.8% of the outstanding stock of TriPath Imaging, Inc. (&#147;TriPath&#148;) which we did not previously own, for a cash purchase price of &#36;9.25 per share, or approximately &#36;362
million.  TriPath develops, manufactures, markets and sells innovative solutions to improve the clinical management of cancer, including detection, diagnosis, staging and treatment.  In connection with the acquisition, BD incurred a charge of
&#36;115 million for acquired in-process research and development.</FONT></P>
<P align="justify">
<FONT face="serif">During the first quarter of 2007, we received an unsolicited offer for the purchase of the blood glucose monitoring (&#147;BGM&#148;) product line. On December 11, 2006, we sold the product line for &#36;20 million and recognized
a pre-tax gain on sale of &#36;15 million. During the second quarter of 2007, the Company recognized post-closing adjustments, thereby increasing the gain on sale by &#36;6 million. Following the sale, prior period Condensed Consolidated Statements
of Income and Cash Flows and related discussions have been restated to separately present the results of the BGM product line as discontinued operations.</FONT></P>
<P align="center">
<FONT size=2 face="serif">15</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">On May 4, 2007, we acquired all of the outstanding shares of Plasso Technology, Ltd. (&#147;Plasso&#148;), a privately-held company, for &#36;10 million in cash.  Plasso is developing the next generation of surface-critical
research tools utilizing functional coating technology for applications in glycomics and cell culture. In connection with the acquisition, BD incurred a charge of &#36;7 million for acquired in-process research and development.</FONT></P>
<P align="justify">
<FONT face="serif">See Note 8 of the Condensed Consolidated Financial Statements for additional discussions on the acquisitions and divestiture. </FONT></P>
<P align="justify">
<FONT face="serif">BD purchases supplies of resins, which are oil-based components used in the manufacture of certain products. During the third quarter of 2007, we incurred slightly higher resin purchase costs than the prior year&#146;s quarter,
primarily due to increases in world oil prices during the late summer 2006.  While the impact of further increases, if any, in resin purchase costs is not expected to be significant on our 2007 operating results, such increases could impact future
operating results.  We are mitigating any such impact through continued improvement in our profit margins resulting from increased sales of products with higher margins, cost reduction programs, productivity improvements and, to a lesser extent,
periodic price increases and adjustments. </FONT></P>
<P align="justify">
<U><FONT face="serif">Results of Operations</FONT></U></P>
<P align="justify">
<U><FONT face="serif">Revenues</FONT></U></P>
<P align="justify">
<FONT face="serif">Refer to Note 5 in the Notes to Condensed Consolidated Financial Statements for segment financial data.</FONT></P>
<P align="justify">
<I><FONT face="serif">Medical Segment </FONT></I></P>
<P align="justify">
<FONT face="serif">Third quarter revenues of &#36;882 million represented an increase of &#36;80 million, or 10%, from the prior year&#146;s quarter, including an estimated &#36;28 million, or 4%, favorable impact due to foreign currency
translation.  Strong sales of Pharmaceutical Systems products contributed to this growth. Global sales of safety-engineered products were &#36;167 million, as compared with &#36;156 million in the prior year&#146;s quarter. For the nine-month period
ended June 30, 2007, global sales of safety-engineered products were &#36;497 million, as compared with &#36;455 million in the prior year&#146;s period. Total BD Medical segment revenues increased by 10% from the prior year nine-month period.
</FONT></P>
<P align="justify">
<I><FONT face="serif">Diagnostics Segment</FONT></I><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Third quarter revenues of &#36;492 million represented an increase of &#36;65 million, or 15%, over the prior year quarter, including an estimated &#36;11 million, or 3%, favorable impact due to foreign currency translation. The
Preanalytical Systems unit of the segment reported revenue growth of 9% over the prior year&#146;s quarter.  Global sales of safety-engineered products totaled &#36;187 million, compared with &#36;162 million in the prior year&#146;s quarter due, in
large part, to strong sales of BD Vacutainer&#174; Push Button Blood Collection Sets in the current year&#146;s quarter. Revenues in the Diagnostic Systems unit of the segment increased 23%, which includes &#36;27 million of revenues from the
TriPath acquisition and also reflects growth from the BD ProbeTec&#153;</FONT><I><FONT face="serif"> </FONT></I><FONT face="serif">ET and BD Phoenix&#153; instruments.  For the nine-month period ended June 30, 2007, global sales of safety-engineered
products were &#36;530 million, as compared with &#36;462 million in the prior year&#146;s</FONT></P>
<P align="center">
<FONT size=2 face="serif">16</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">period. Total BD Diagnostics segment revenues increased by 9% from the prior year nine-month period, which includes &#36;59 million of revenues from TriPath. </FONT></P>
<P align="justify">
<I><FONT face="serif">Biosciences Segment</FONT></I><B><I><FONT face="serif"> </FONT></I></B></P>
<P align="justify">
<FONT face="serif">Third quarter revenues of &#36;258 million represented an increase of &#36;29 million, or 13%, over the prior year&#146;s quarter, including an estimated &#36;7 million, or 3%, favorable impact due to foreign currency translation.
Flow cytometry instrument and reagent sales, as well as sales of advanced bioprocessing products, contributed to growth. For the nine-month period ended June 30, 2007, total BD Biosciences segment revenues increased by 12% from the prior year
period.</FONT></P>
<P align="justify">
<U><FONT face="serif">Segment Operating Income</FONT></U></P>
<P align="justify">
<I><FONT face="serif">Medical Segment </FONT></I></P>
<P align="justify">
<FONT face="serif">Segment operating income for the third quarter was &#36;247 million, or 28.0% of Medical revenues, compared with &#36;212 million, or 26.4%, in the prior year&#146;s quarter. Gross profit margin increased moderately due to an
improved product mix of sales, combined with increased manufacturing productivity. See further discussion on gross profit margin below. Selling and administrative expense as a percent of Medical revenues in the third quarter of 2007 was slightly
lower than the third quarter of 2006, due to spending controls.  Research and development expenses for the quarter increased &#36;3.3 million, or 14%, reflecting increased investment in new products and platforms. Segment operating income for the
nine-month period was &#36;728 million, or 28.5% of Medical revenues, compared with &#36;642 million, or 27.6%, in the prior year&#146;s period. </FONT></P>
<P align="justify">
<I><FONT face="serif">Diagnostics Segment </FONT></I></P>
<P align="justify">
<FONT face="serif">Segment operating income for the third quarter was &#36;115 million, or 23.5% of Diagnostics revenues, compared with &#36;104 million, or 24.4%, in the prior year&#146;s quarter. Gross profit margin was higher than the third
quarter of 2006, primarily due to a favorable sales mix of products with higher margins, as well as productivity gains.  See further discussion on gross profit margin below. Selling and administrative expense as a percentage of Diagnostics revenues
in the third quarter of 2007 was higher than the comparable amount in the third quarter of 2006, largely due to the impact of TriPath and GeneOhm. Research and development expenses in the third quarter of 2007 increased &#36;12.3 million, or 57%,
primarily due to investment in new products and incremental TriPath and GeneOhm expenses.  Segment operating income for the nine-month period was &#36;224 million, or 15.9% of Diagnostics revenues, compared with &#36;281 million, or 21.9%, in the
prior year&#146;s period and reflects the impact of the acquired in-process research and development charges for TriPath in 2007 and GeneOhm in 2006.</FONT></P>
<P align="justify">
<I><FONT face="serif">Biosciences Segment</FONT></I></P>
<P align="justify">
<FONT face="serif">Segment operating income for the third quarter was &#36;59 million, or 22.7% of Biosciences revenues, compared with &#36;52 million, or 22.9%, in the prior year&#146;s quarter. Operating income included the acquired in-process
research and development charge of &#36;7 million associated with the Plasso acquisition, as further discussed above, which reduced operating income as a percentage of revenues by 2.9% . Gross profit margin as a percentage of revenues increased due
to improved production efficiencies, as well as increased sales of products with higher margins. See further discussion on gross profit margin below. Selling and administrative expense as a percent of Biosciences revenues for the quarter decreased
compared with the prior year&#146;s quarter, as a result of continued spending controls. Research and development spending in the quarter increased &#36;1.9 million, or 11%, reflecting increased investment in new product development.</FONT></P>
<P align="center">
<FONT size=2 face="serif">17</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">Segment operating income for the nine-month period was &#36;183 million, or 24.4% of Biosciences revenues, compared with &#36;158 million, or 23.6%, in the prior year&#146;s period.</FONT><FONT color="#ff0000" face="serif">
</FONT></P>
<P align="justify">
<U><FONT face="serif">Gross Profit Margin</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Gross profit margin was 51.5% for the third quarter and 51.9% for the nine-month period, compared with 50.6% and 51.3%, respectively, for the comparable prior year periods.  Gross profit margin in the third quarter of 2007 as
compared with the prior year&#146;s period reflected an estimated 0.5% net improvement relating primarily to increased sales of products with relatively higher margins and productivity gains and an estimated 0.4% impact from foreign currency
translation. Gross profit margin in the nine-month period of 2007 as compared with the prior period reflected an estimated 0.7% net improvement relating to increased sales of products with relatively higher margins and improvement associated
primarily with productivity gains. These improvements were partially offset by an estimated 0.1% impact from foreign currency translation. We expect gross profit margin to improve, on a reported basis, by about 70 basis points in 2007, with
TriPath&#146;s operations accounting for 10 basis points. </FONT></P>
<P align="justify">
<U><FONT face="serif">Selling and Administrative Expense</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Selling and administrative expense was 25.3% of revenues for the third quarter and 25.5% for the nine-month period, compared with 25.7% and 25.0%, respectively, for the prior year&#146;s periods.  Aggregate expenses for the
current period reflect increases in base spending of &#36;17 million and in expenses associated with the GeneOhm and TriPath operations of &#36;11 million, as well as an unfavorable foreign exchange impact of &#36;10 million. Aggregate expenses in
the nine-month period reflect increases in base spending of &#36;55 million and in expenses associated with the GeneOhm and TriPath operations of &#36;35 million.  Increases in selling and administrative expense for the nine-month period also
reflect the absence of proceeds from insurance settlements of &#36;17 million received in the prior year&#146;s period in connection with the Company&#146;s previously owned latex glove business, as well as an unfavorable foreign exchange impact of
&#36;26 million.  Selling and administrative expense as a percentage of revenues is expected to increase, on a reported basis, by about 40 basis points in 2007, with 20 basis points attributable to TriPath&#146;s operations.</FONT></P>
<P align="justify">
<U><FONT face="serif">Research and Development Expense</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Research and development expense of &#36;93 million for the third quarter increased 21%, compared with the prior year&#146;s amount of &#36;77 million, with more than half of the increase due to Tripath&#146;s operations.
Research and development expense of &#36;260 million for the nine-month period increased 18%, compared with the prior year&#146;s amount of &#36;219 million. The increase in research and development expenditures reflect increased spending for new
programs in each of our segments for the three and nine-month periods of 2007.  We anticipate Research and development expense to increase, on a reported basis, by about 20% for 2007, with 8% due to the impact of TriPath&#146;s
operations.</FONT></P>
<P align="justify">
<U><FONT face="serif">Non-Operating Expense and Income</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Interest income was &#36;12 million in both the third quarter and in the prior year&#146;s period. Interest income was &#36;37 million in the nine-month period, compared with &#36;44 million in the prior year&#146;s period, and
reflected lower cash balances. Interest expense was &#36;12 million in the third quarter and &#36;36 million in the nine-month period, compared with &#36;15 million and &#36;52 million, respectively, in the prior year&#146;s periods, which reflect
lower debt and higher levels of capitalized interest. </FONT></P>
<P align="center">
<FONT size=2 face="serif">18</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<U><FONT face="serif">Income Taxes</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">The income tax rate was 27.1% for the third quarter.  The nine-month tax rate was 29.9% compared with the prior year&#146;s rate of 28.5% .  The increase is principally due to the non-deductibility of the acquired in-process
research and development charges associated with the TriPath and Plasso acquisitions, which was partially offset by the impact of approximately 0.5% resulting from the retroactive reinstatement of the research and experimentation tax credit. The
prior year&#146;s nine-month rate reflected the non-deductibility of the acquired in-process research and development charge associated with the GeneOhm acquisition, as well as the impact relating to the proceeds received from insurance settlements
of approximately 0.2% .  The Company expects the reported tax rate for 2007 to be approximately 29%.</FONT></P>
<P align="justify">
<U><FONT face="serif">Income from Continuing Operations and Diluted Earnings Per Share from Continuing</FONT></U><FONT face="serif"> </FONT><U><FONT face="serif">Operations</FONT></U></P>
<P align="justify">
<FONT face="serif">Income from continuing operations and diluted
earnings per share from continuing operations for the third quarter of 2007 were &#36;240 million and 95 cents, respectively. Income from continuing operations and diluted earnings per share from continuing operations for the prior year&#146;s
second quarter were &#36;211 million and 83 cents, respectively.  The acquired in-process research and development charges associated with the Plasso acquisition reduced income from continuing operations for the current year&#146;s quarter by &#36;7
million and diluted earnings per share from continuing operations by 3 cents.  For the nine-month periods, income from continuing operations and diluted earnings per share from continuing operations were &#36;607 million and &#36;2.38, respectively,
in 2007, and &#36;598 million and &#36;2.33, respectively, in 2006. The acquired in-process research and development charges associated with the TriPath and Plasso acquisitions reduced income from continuing operations for the current year&#146;s
nine-month period by &#36;122 million and diluted earnings per share from continuing operations by 48 cents. The prior year&#146;s nine-month period reflected the acquired in-process research and development charge associated with GeneOhm of &#36;53
million or 21 cents.  Proceeds from insurance settlements increased income from continuing operations in the prior year&#146;s nine-month period by &#36;11 million and diluted earnings per share from continuing operations by 4 cents.</FONT></P>
<P align="justify">
<U><FONT face="serif">Liquidity and Capital Resources</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Net cash provided by continuing operating activities, which continues to be our primary source of funds to finance operating needs and capital expenditures, was &#36;875 million during the first nine months of 2007, compared with
&#36;682 million in the same period in 2006.  Net cash provided by continuing operations in the first nine months of the current and prior year was reduced by changes in the pension obligation, resulting primarily from discretionary cash
contributions of &#36;75 million and &#36;150 million, respectively.</FONT><FONT size=2 face="sans-serif"> </FONT></P>
<P align="justify">
<FONT face="serif">Net cash used for continuing investing activities for the first nine months of the current year was &#36;781 million, compared with &#36;558 million in the prior year period. The current year amount reflects the payment of
&#36;340 million of net cash for the TriPath acquisition, and the prior year amount reflects the payment of &#36;231 million for the GeneOhm acquisition. Capital expenditures were &#36;366 million in the first nine months of 2007 and &#36;258
million in the same period in 2006. We expect capital spending for 2007 to be in the &#36;600 million range.</FONT></P>
<P align="justify">
<FONT face="serif">Net cash used for continuing financing activities for the first nine months of the current year was &#36;672 million, compared with &#36;431 million in the prior year period. As of June 30, 2007, total</FONT></P>
<P align="center">
<FONT size=2 face="serif">19</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">debt of &#36;1.2 billion represented 20.7% of total capital (shareholders' equity, net non-current deferred income tax liabilities, and debt), versus 25.8% at September 30, 2006. Short-term debt decreased to 18% of total debt at
the end of the nine-month period, from 31% at September 30, 2006. </FONT></P>
<P align="justify">
<FONT face="serif">For the first nine months of the current year, the Company repurchased &#36;412 million of its common stock, compared with approximately &#36;433 million of its common stock in the prior year period. At June 30,
2007, authorization to repurchase an additional 1.6 million common shares remained. Our Board of Directors authorized an additional repurchase program for 10 million shares on July 24, 2007.  Stock repurchases were offset, in part, by the issuance
of common stock from treasury upon the exercise of stock options by employees. </FONT></P>
<P align="justify">
<FONT face="serif">We have in place a commercial paper borrowing program that is available to meet our short-term financing needs, including working capital requirements.  Borrowings outstanding under this program were &#36;200
million at June 30, 2007. During the first quarter of 2007, we amended our syndicated credit facility to increase the amount available from &#36;900 million to &#36;1 billion and extend the expiration date from August 2009 to December 2011.  This
credit facility, under which there were no borrowings outstanding at June 30, 2007, provides backup support for our commercial paper program and can also be used for other general corporate purposes.  This credit facility includes a single financial
covenant that requires BD to maintain an interest expense coverage ratio (ratio of earnings before income taxes, depreciation and amortization to interest expense) of not less than 5-to-1 for the most recent four consecutive fiscal quarters. On the
last eight measurement dates, this ratio has ranged from 17-to-1 to 21-to-1. In addition, we have informal lines of credit outside the United States.</FONT></P>
<P align="justify">
<U><FONT face="serif">Adoption of New Accounting Standards</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">In July 2006, the Financial Accounting Standards Board (the &#147;FASB&#148;) issued Interpretation No. 48 &#147;Accounting for Uncertainty in Income Taxes&#148; (&#147;FIN 48&#148;). FIN 48 prescribes guidance for
recognition, measurement, and disclosure of uncertain tax positions recognized in financial statements in accordance with Statement of Financial Accounting Standards No. 109 &#147;Accounting for Income Taxes&#148;. The provisions of this
interpretation will be applied to all tax positions upon its initial adoption. The Company is required to adopt this interpretation in fiscal year 2008 and the cumulative effect, if any, of applying this interpretation will be reported as an
adjustment to the opening balance of retained earnings for such fiscal year. The Company is currently evaluating the impact of FIN 48 on its consolidated financial statements. </FONT></P>
<P align="justify">
<FONT face="serif">In September 2006, the FASB issued SFAS No. 158 &#147;Employers&#146; Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106 and 132(R)&#148;
(&#147;SFAS No. 158&#148;).  This statement requires the Company to recognize the overfunded or underfunded status of a defined benefit postretirement plan as an asset or liability in its consolidated balance sheet and to recognize changes in the
funded status in the year in which the changes occur through comprehensive income.  SFAS No. 158 also requires the funded status of a plan to be measured as of the balance sheet date and provides for additional disclosure requirements.  As required,
the Company will adopt the recognition and disclosure provision of this statement at the end of fiscal year 2007. Based on the underfunded status of the plans as of September 30, 2006, this provision could be material to the Company&#146;s
shareholder&#146;s equity. The Company expects no impact to the measurement date of its plans, as the plans are currently measured at its fiscal year-end. </FONT></P>
<P align="center">
<FONT size=2 face="serif">20</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<U><FONT face="serif">Cautionary Statement Pursuant to Private Securities Litigation Reform Act of 1995 -- &#147;Safe</FONT></U><FONT face="serif"> </FONT><U><FONT face="serif">Harbor&#148; for Forward-Looking Statements</FONT></U></P>

<P align="justify">
<FONT face="serif"> The Private Securities Litigation Reform Act of 1995 (the &#147;Act&#148;) provides a safe harbor for forward-looking statements made by or on behalf of BD. BD and its representatives may from time to time make certain forward-looking
statements, both written and oral, including statements contained in this report and filings with the Securities and Exchange Commission (&#147;SEC&#148;) and in our other reports to shareholders. Forward-looking statements may be identified by the
use of words like &#147;plan,&#148; &#147;expect,&#148; &#147;believe,&#148; &#147;intend,&#148; &#147;will,&#148; &#147;anticipate,&#148; &#147;estimate&#148; and other words of similar meaning in conjunction with, among other things, discussions
of future operations and financial performance, as well as our strategy for growth, product development, regulatory approvals, market position and expenditures.  All statements which address operating performance or events or developments that we
expect or anticipate will occur in the future -- including statements relating to volume growth, sales and earnings per share growth, gross profit margins, various expenditures and statements expressing views about future operating results -- are
forward-looking statements within the meaning of the Act. </FONT></P>
<P align="justify">
<FONT face="serif">Forward-looking statements are based on current expectations of future events. The forward-looking statements are and will be based on management's then-current views and assumptions regarding future events and operating
performance, and speak only as of their dates. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from our expectations and projections.
Investors are therefore cautioned not to place undue reliance on any forward-looking statements. Furthermore, we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events and
developments or otherwise. </FONT></P>
<P align="justify">
<FONT face="serif">The following are some important factors that could cause our actual results to differ from our expectations in any forward-looking statements: </FONT></P>
<UL>
<LI>
<P align="justify"><FONT face="serif">Regional, national and foreign economic factors, including inflation and fluctuations in interest rates and foreign currency exchange rates and the potential effect of such
fluctuations on revenues, expenses and resulting margins, as well as on competition in certain markets.</FONT></P>
</LI>
<LI>
<P align="justify"><FONT face="serif">We operate in a highly competitive environment.
    New product introductions by our current or future competitors could adversely
    affect our ability to compete in the global market.  For example, new forms
    of inhaled insulin or other methods of insulin delivery could adversely impact
    sales of our insulin injection devices. Patents attained by competitors,
    particularly as</FONT>
<FONT face="serif">patents on our products expire, may also adversely impact
our competitive position. Certain competitors have established manufacturing
sites or have contracted with suppliers in low-cost manufacturing locations as
a means to lower their costs. New entrants may also appear.</FONT></P>
</LI>
<LI>
<P align="justify"><FONT face="serif">Changes in domestic and foreign healthcare industry practices and regulations resulting in increased pricing pressures, including the continued consolidation among healthcare</FONT>
<FONT face="serif">providers; trends toward managed care and healthcare cost containment and government laws and regulations relating to sales and promotion, reimbursement and pricing generally.</FONT></P></LI>
</UL>
<P align="center">
<FONT size=2 face="serif">21</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<UL>
<LI>
<P align="justify"><FONT face="serif">The effects, if any, of governmental and media activities regarding the business practices of group purchasing organizations, which negotiate product prices on behalf of their
member hospitals with BD and other suppliers.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Fluctuations in the cost and availability of raw materials and the ability to maintain favorable supplier arrangements and relationships (particularly with respect to sole-source
suppliers) and the potential adverse effects of any disruption in the availability of such raw materials.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Our ability to obtain the anticipated benefits of any restructuring programs, if any, that we may undertake.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Adoption of or changes in government laws and regulations affecting domestic and foreign operations, including those relating to trade, monetary and fiscal policies, taxation,</FONT>
<FONT face="serif">environmental matters, sales practices, price controls, licensing and regulatory approval of new products, or changes in enforcement practices with respect to any such laws and regulations. In particular, environmental laws, particularly with respect to the emission of greenhouse gases, are becoming more stringent throughout the world, which may increase our
costs of operations or necessitate changes in our manufacturing plants or processes.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Fluctuations in U.S. and international governmental funding and policies for life science research.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Difficulties inherent in product development, including the potential inability to successfully continue technological innovation, complete clinical trials, obtain regulatory approvals
in the United States and abroad, or gain and maintain market approval of products, as well as the possibility of encountering infringement claims by competitors with respect to patent or
other intellectual property rights, all of which can preclude or delay commercialization of a product.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Pending and potential litigation or other proceedings adverse to BD, including antitrust claims, product liability claims, and patent infringement claims, as well as other risks
and uncertainties detailed from time to time in our SEC filings.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">The effects, if any, of adverse media exposure or other publicity regarding BD&#146;s business or operations.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Our ability to achieve earnings forecasts, which are generated based on projected volumes and sales of many product types, some of which are more profitable than others. There
can be no assurance that we will achieve the projected level or mix of product sales.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">The effect of market fluctuations on the value of assets in BD&#146;s pension plans and the possibility that BD may need to make additional contributions to the plans as a result of
any decline in the value of such assets.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Our ability to effect infrastructure enhancements and incorporate new systems technologies into our operations.</FONT></P></LI>
</UL>
<P align="center">
<FONT size=2 face="serif">22</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<UL>
<LI>
<P align="justify"><FONT face="serif">Product efficacy or safety concerns resulting in product recalls, regulatory action on the part of the FDA (or foreign counterparts) or declining sales.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Economic and political conditions in international markets, including civil unrest, terrorist activity, governmental changes and restrictions on the ability to transfer capital
across borders.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">The effects of natural disasters, including hurricanes or pandemic diseases, on our ability to manufacture our products, particularly where production of a product line is concentrated
in one or more plants, or on our ability to source components from suppliers that are needed for such manufacturing.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Our ability to penetrate developing and emerging markets, which also depends on economic and political conditions, and how well we are able to acquire or form strategic business</FONT>
<FONT face="serif">alliances with local companies and make necessary infrastructure enhancements to production facilities, distribution networks, sales equipment and technology.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">The impact of business combinations, including acquisitions and divestitures, both internally for BD and externally, in the healthcare industry.</FONT></P></LI>
<LI>
<P align="justify"><FONT face="serif">Issuance of new or revised accounting standards by the Financial Accounting Standards Board or the SEC.</FONT></P></LI>
</UL>
<P align="justify">
<FONT face="serif">The foregoing list sets forth many, but not all, of the factors that could impact our ability to achieve results described in any forward-looking statements. Investors should understand that it is not possible to predict or
identify all such factors and should not consider this list to be a complete statement of all potential risks and uncertainties.</FONT></P>
<P align="center">
<FONT size=2 face="serif">23</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">Item 3. </FONT><U><FONT face="serif">Quantitative and Qualitative Disclosures About Market Risk</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">There have been no material changes in information reported since the end of the fiscal year ended September 30, 2006. </FONT></P>
<P align="justify">
<FONT face="serif">Item 4. </FONT><U><FONT face="serif">Controls and Procedures</FONT></U><FONT face="serif"> </FONT></P>
<P align="justify">
<FONT face="serif">An evaluation was carried out by BD&#146;s management, with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of BD&#146;s disclosure controls and
procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934) as of June 30, 2007. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the design and operation of these disclosure
controls and procedures were, as of the end of the period covered by this report, adequate and effective to ensure that material information relating to BD and its consolidated subsidiaries would be made known to them by others within these
entities. There were no changes in our internal control over financial reporting during the fiscal quarter ended June 30, 2007 identified in connection with the above-referenced evaluation that have materially affected, or are reasonably likely to
materially affect, our internal control over financial reporting. </FONT></P>
<P align="center">
<FONT size=2 face="serif">24</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="justify">
<FONT face="serif">PART II - OTHER INFORMATION</FONT></P>

<table width="100%"  border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="10%"><FONT face="serif">Item 1.</FONT><FONT face="serif">&nbsp; </FONT></td>
    <td><FONT face="serif">Item 1. </FONT><U><FONT face="serif">Legal Proceedings</FONT></U><FONT face="serif">&nbsp; </FONT></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><div align="justify"><FONT face="serif">We are involved, both as a plaintiff and a defendant,
          in various legal proceedings which arise in the ordinary course of business,
          including product liability and environmental matters as set forth in
    our 2006 Annual Report on Form 10-K. </FONT></div></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><div align="justify"><FONT face="serif">Since March 31, 2007, the following developments have
    occurred with respect to the legal proceedings in which we are involved:</FONT></div></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><U><FONT face="serif">Retractable Technologies, Inc.</FONT></U><FONT face="serif">&nbsp; </FONT></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><div align="justify"><FONT face="serif">As was previously reported, in
          June 2007, Retractable Technologies, Inc. (&#147;plaintiff&#148;) filed
          a complaint against BD under the caption </FONT><U><FONT face="serif">Retractable</FONT></U><FONT face="serif"> </FONT><U><FONT face="serif">Technologies,
          Inc. vs. Becton Dickinson and Company</FONT></U><FONT face="serif"> (Civil
          Action No. 2:07-cv-250, United States District Court, Eastern District
          of Texas). Plaintiff alleges that the BD Integra&#153; syringes infringe
          patents licensed exclusively to the plaintiff. This patent claim was
          not covered by the release contained in the July 2004 settlement agreement
    between BD and plaintiff to settle the lawsuit previously filed by plaintiff. </FONT></div></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><div align="justify"><FONT face="serif">In its complaint, plaintiff also
          alleges that BD engaged in false advertising with respect to certain
          of BD&#146;s safety-engineered
          products in violation of the Lanham Act; acted to exclude the plaintiff
          from various product markets and to maintain its market share through,
          among other things, exclusionary contracts in violation of state and
          Federal antitrust laws; and engaged in unfair competition. The non-patent
          claims purport to relate to actions allegedly taken by BD following
    the date of the July 2004 settlement agreement referenced above. </FONT></div></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><div align="justify"><FONT face="serif">Plaintiff seeks treble damages,
          attorney&#146;s fees
          and injunctive relief. BD believes it has meritorious defenses to these
    claims and intends to vigorously defend this lawsuit. </FONT></div></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><U><FONT face="serif">Antitrust Class Action Suits</FONT></U></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><div align="justify"><FONT face="serif">As was previously reported, ten
          purported antitrust class action lawsuits have been brought against
          BD by direct and indirect purchasers of BD&#146;s products. Our motions
          to dismiss each of the consolidated complaints filed by the direct
          and indirect purchaser plaintiffs were denied by the court. Class certification
    motions in these actions are scheduled to be filed by the end of 2007. </FONT></div></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td><U><FONT face="serif">bioM&eacute;rieux</FONT></U><B><I><FONT face="serif"> </FONT></I></B></td>
  </tr>
  <tr>
    <td width="10%">&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><div align="justify"><FONT face="serif">As was previously reported, in
          April 2007, bioM&eacute;rieux
          SA initiated an arbitration proceeding with the International Chamber
          of Commerce International Court of Arbitration in Paris, France, against
          GeneOhm Sciences Canada (&#147;GeneOhm&#148;), a subsidiary of BD.
    The arbitration related to a sublicense agreement under which </FONT></div></td>
  </tr>
</table>
<P align="center">
<FONT size=2 face="serif">25</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<table width="100%"  border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="10%">&nbsp;</td>
    <td><div align="justify"><FONT face="serif">bioM&eacute;rieux granted certain
          patent rights to GeneOhm relating to a method for the detection of
          methicillin-resistant </FONT><I><FONT face="serif">Staphylococcus
          aureus</FONT></I><FONT face="serif"> (&#147;MRSA&#148;). In the arbitration,
          bioM&eacute;rieux alleged, among other things, that GeneOhm fraudulently
          induced bioM&eacute;rieux into entering into the sublicense and assigned
          its rights in violation of the sublicense. In the arbitration, bioM&eacute;rieux
          sought monetary damages and to terminate the patent rights granted
          to GeneOhm under the sublicense agreement. </FONT></div></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><div align="justify"><FONT face="serif">BD and bioM&eacute;rieux subsequently
          entered into an agreement to settle the arbitration proceeding. The
          financial terms of the settlement will not have any material impact
          on BD. </FONT></div></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><U><FONT face="serif">Oil-For-Food Programme</FONT></U><FONT face="serif">&nbsp; </FONT></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><div align="justify"><FONT face="serif">As was previously reported, Becton
          Dickinson France, S.A., a subsidiary of BD, was listed among approximately
          2,200 other companies in an October 2005 report of the Independent
          Inquiry Committee (&#147;IIC&#148;) of the United Nations (&#147;UN&#148;) as having been
          involved in humanitarian contracts in which unauthorized payments were
          suspected of having been made to the Iraqi Government in connection with
          the UN&#146;s Oil-for-Food Programme (the &#147;Programme&#148;). BD
          conducted an internal review and found no evidence that BD or any BD
          employee or representative of BD made, authorized, or approved improper
          payments to the Iraqi Government in connection with the Programme. BD
          reported the results of its internal review to the Vendor Review Committee
          of the United Nations Procurement Service. In May 2007, the French Judicial
          Police conducted searches of BD&#146;s offices in France with respect
          to the matters that were the subject of the 2005 IIC report. BD was
          informed that it is one of a number of companies named in the IIC report
          that is being investigated by the French Judicial Police. BD is cooperating
    fully with the investigation. </FONT></div></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><U><FONT face="serif">El Seif Development</FONT></U><FONT face="serif">&nbsp; </FONT></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><div align="justify"><FONT face="serif">In July 2007, BD received notice
          of a suit instituted in Saudi Arabia by El Seif Development (&#147;El Seif&#148;),
          a former BD distributor (Case No. 7516, Board of Grievances, Saudi
          Arabia). El Seif seeks monetary damages arising out of the termination
          of its distributor agreement and other contractual arrangements with
    BD.</FONT></div></td>
  </tr>
</table>


<P align="center">
<FONT size=2 face="serif">26</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<table width="100%"  border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="10%">&nbsp;</td>
    <td><FONT face="serif">BD believes that it has meritorious defenses to these
        claims and intends to vigorously defend this lawsuit. </FONT></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><U><FONT face="serif">Summary</FONT></U></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><div align="justify"><FONT face="serif">Given the uncertain nature of
          litigation generally, BD is not able in all cases to estimate the amount
          or range of loss that could result from an unfavorable outcome of the
          litigation to which BD is a party. In accordance with U.S. generally
          accepted accounting principles, BD establishes accruals to the extent
          probable future losses are estimable (in the case of environmental
          matters, without considering possible third-party recoveries). In view
          of the uncertainties of litigation, BD could incur charges in excess
          of any currently established accruals and, to the extent available,
          excess liability insurance. In the opinion of management, any such
          future charges, individually or in the aggregate, could have a material
          adverse effect on BD&#146;s consolidated results of operations
          and consolidated cash flows in the period or periods in which they
    are recorded or paid. </FONT></div></td>
  </tr>
</table>


<P align="center">
<FONT size=2 face="serif">27</FONT></P>

<HR noshade width="100%" size=4>

<P STYLE="page-break-before:always"></P><PAGE>




<table width="100%"  border="0" cellspacing="0" cellpadding="0">
  <tr>
    <td width="10%"><FONT face="serif">Item 1A.</FONT></td>
    <td><U><FONT face="serif">Risk Factors</FONT></U><FONT face="serif">&nbsp; </FONT></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><div align="justify"><FONT face="serif">There have been no material changes from the risk
          factors disclosed in Part 1, Item 1A, of our Annual Report on Form 10-K
    for the 2006 fiscal year. </FONT></div></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td><FONT face="serif">Item 2. </FONT></td>
    <td><U><FONT face="serif">Unregistered
    Sales of Equity Securities and Use of Proceeds</FONT></U></td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td>&nbsp;</td>
  </tr>
  <tr>
    <td>&nbsp;</td>
    <td><div align="justify"><FONT face="serif">The table below sets forth certain information regarding
          our purchases of common stock of BD during the quarter ended June 30,
    2007.</FONT></div></td>
  </tr>
</table>




<P align="center">
<U><FONT face="serif">Issuer Purchases of Equity Securities</FONT></U><FONT face="serif"> </FONT></P>
<TABLE width="100%" border=1 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left nowrap style="border-bottom:1px solid #000000;"><FONT size=2 face="serif"> <FONT size=2 face="serif">For
        the three months ended</FONT> <br>
        June
      30, 2007<br>&nbsp;
  </FONT>

  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif">Total
Number of</FONT> <br>
Shares Purchased</FONT> <br>
(1)</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif">Average
Price</FONT> <br>
Paid per</FONT> <br>
Share</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif">Total
Number of</FONT> <br>
Shares
Purchased</FONT> <br>
as
Part of</FONT> <br>
Publicly</FONT> <br>
Announced Plans</FONT> <br>
or Programs (2)</FONT>
  </TD>
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif"> <FONT size=2 face="serif">Maximum
Number</FONT> <br>
of
Shares that May</FONT> <br>
Yet
Be Purchased</FONT> <br>
Under the Plans or</FONT> <br>
Programs (2)</FONT>
  </TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">April 1 &#150; 30, 2007</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">302,933</FONT>
  </TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;78.49</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
 <FONT size=2 face="serif">300,000</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
 <FONT size=2 face="serif">3,735,814</FONT>
  </TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">May 1 &#150; 31, 2007</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,136,516</FONT>
  </TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;78.57</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
 <FONT size=2 face="serif">1,134,000</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
 <FONT size=2 face="serif">2,601,814</FONT>
  </TD>
  </TR>
<TR valign="bottom" bgcolor="#E5FFFF">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">June 1 &#150; 30, 2007</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">1,000,233</FONT>
  </TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;74.96</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
 <FONT size=2 face="serif">1,000,000</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
 <FONT size=2 face="serif">1,601,814</FONT>
  </TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">Total</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">2,439,682</FONT>
  </TD>
  <TD align=center nowrap style="border-bottom:1px solid #000000;">
<FONT size=2 face="serif">&#36;77.08</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
 <FONT size=2 face="serif">2,434,000</FONT>
  </TD>
  <TD align=right nowrap style="border-bottom:1px solid #000000;">
 <FONT size=2 face="serif">1,601,814</FONT>
  </TD>
  </TR>
</TABLE>
<BR>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR>
  <TD width="10%" valign=top nowrap>&nbsp;</TD>
  <TD width="4%" valign=top nowrap>
<FONT size=2 face="serif">(1)</FONT></TD>
  <TD>
<P align="justify"><FONT size=2 face="serif">Includes 2,922 shares purchased during the quarter in open market transactions by the trustee under BD&#146;s Deferred Compensation Plan and 1996 Directors&#146; Deferral Plan, and 2,760 shares delivered
to BD in connection with stock option exercises.</FONT></P>
  </TD>
</TR>
<TR>
  <TD nowrap valign=top>&nbsp;</TD>
  <TD nowrap valign=top>&nbsp;</TD>
  <TD>&nbsp;</TD>
</TR>
<TR>
  <TD nowrap valign=top>&nbsp;</TD>
  <TD nowrap valign=top>
<FONT size=2 face="serif">(2)</FONT></TD>
  <TD>
<P align="justify"><FONT size=2 face="serif">These repurchases were made pursuant to a repurchase program covering 10 million shares authorized by the Board of Directors of BD (the &#147;Board&#148;) on November 22, 2005 (the &#147;2005
Program&#148;). There is no expiration date for the 2005 Program. On July 24, 2007, the Board authorized an additional repurchase program for 10 million shares.</FONT></P>
  </TD>
</TR>
<TR><TD colspan=3>&nbsp;</TD></TR></TABLE>



<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD width="10%" align=left nowrap>
<FONT face="serif">Item 3.</FONT>
  </TD>
  <TD colspan="2">
    <U><FONT face="serif">Defaults Upon Senior Securities</FONT></U>
  </TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD width="4%">&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD colspan="2">
    <FONT face="serif">Not applicable.</FONT>
  </TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>
<FONT face="serif">Item 4.</FONT>
  </TD>
  <TD colspan="2">
    <U><FONT face="serif">Submission of Matters to a Vote of Security Holders</FONT></U>
  </TD>
  </TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;

  </TD>
  <TD colspan="2">
    <FONT face="serif">Not applicable.</FONT>
  </TD>
  </TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">28</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD width=6% align=left nowrap>
<FONT face="serif">Item 5.</FONT>
  </TD>
  <TD width=3% align=left nowrap>&nbsp;</TD>
  <TD width="15%" align=left nowrap><U><FONT face="serif">Other Information</FONT></U> </TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;</TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;

  </TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap><FONT size=2 face="serif">Not applicable.</FONT> </TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;</TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>
<FONT face="serif">Item 6.</FONT>
  </TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap><U><FONT face="serif">Exhibits</FONT></U> </TD>
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;</TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;

  </TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10
<FONT size=2 face="serif">(o)</FONT> </FONT>
  </TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">2004 Employee and Director Equity-Based Compensation Plan, as</FONT>
<FONT size=2 face="serif">amended and restated as of March 27, 2007.</FONT> </TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;</TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;

  </TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit 31</FONT>
  </TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Certifications of Chief Executive Officer and Chief Financial
<FONT size=2 face="serif">Officer, pursuant to SEC Rule 13a - 14(a).</FONT> </FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;</TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD width="5%" align=left nowrap>&nbsp;

  </TD>
  <TD width="3%" align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibit 32</FONT>
  </TD>
  <TD align=right nowrap>&nbsp;</TD>
  <TD align=left nowrap>
<FONT size=2 face="serif">Certifications of Chief Executive Officer and Chief Financial</FONT>
<FONT size=2 face="serif">Officer, pursuant to Rule 13a - 14(b) and Section 1350
of<br>
Chapter
<FONT size=2 face="serif">63 of Title 18 of the U.S. Code.</FONT>
  </FONT> </TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">29</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="center">
<FONT face="serif">SIGNATURES</FONT></P>
<P align="justify">
<FONT face="serif"> Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</FONT></P>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left width=31% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U><FONT face="serif">Becton, Dickinson and Company</FONT></U>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT face="serif">(Registrant)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>
<FONT face="serif">Dated:</FONT>
<FONT face="serif">August 8, 2007</FONT> </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>&nbsp;

  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<U><FONT face="serif">/s/ John R. Considine&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></U>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT face="serif">John R. Considine</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Senior Executive Vice President and</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Chief Financial Officer</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT face="serif">(Principal Financial Officer)</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<U><FONT face="serif">/s/ William A. Tozzi</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT face="serif">William A. Tozzi</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT face="serif">Vice President and Controller</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=9% nowrap>&nbsp;

  </TD>
  <TD width=2%>&nbsp;
  </TD>
  <TD align=left nowrap>
<FONT face="serif">(Chief Accounting Officer)</FONT>
  </TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">30</FONT></P>

<HR noshade width="100%" size=4>



<P STYLE="page-break-before:always"></P><PAGE>


<P align="center">
<FONT face="serif">INDEX TO EXHIBITS </FONT></P>
<TABLE width="100%" border=0 cellspacing=0 cellpadding=0>
<TR valign="bottom">
  <TD align=left width=17% nowrap>
<U><FONT face="serif">Exhibit Number</FONT></U>
  </TD>
  <TD align=left width=77% nowrap>
<U><FONT face="serif">Description of Exhibits</FONT></U>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left width=17% nowrap>
<FONT face="serif">10
<FONT face="serif">(o)</FONT> </FONT>
  </TD>
  <TD align=left width=77% nowrap>
<FONT face="serif">2004 Employee and Director Equity-Based Compensation Plan, as amended</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=17% nowrap>&nbsp;

  </TD>
  <TD align=left width=77% nowrap>
<FONT face="serif">and restated as of March 27, 2007.</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left width=17% nowrap>
<FONT face="serif">31</FONT>
  </TD>
  <TD align=left width=77% nowrap>
<FONT face="serif">Certifications of Chief Executive Officer and Chief Financial Officer,</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=17% nowrap>&nbsp;

  </TD>
  <TD align=left width=77% nowrap>
<FONT face="serif">pursuant to SEC Rule 13a - 14(a).</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left nowrap>&nbsp;</TD>
  <TD align=left nowrap>&nbsp;</TD>
</TR>
<TR valign="bottom">
  <TD align=left width=17% nowrap>
<FONT face="serif">32</FONT>
  </TD>
  <TD align=left width=77% nowrap>
<FONT face="serif">Certifications of Chief Executive Officer and Chief Financial Officer,</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=17% nowrap>&nbsp;

  </TD>
  <TD align=left width=77% nowrap>
<FONT face="serif">pursuant to Rule 13a - 14(b) and Section 1350 of Chapter 63 of Title 18 of the</FONT>
  </TD>
</TR>
<TR valign="bottom">
  <TD align=left width=17% nowrap>&nbsp;

  </TD>
  <TD align=left width=77% nowrap>
<FONT face="serif">U.S. Code.</FONT>
  </TD>
</TR>
</TABLE>
<BR>
<P align="center">
<FONT size=2 face="serif">31</FONT></P>

<HR noshade width="100%" size=4>


</BODY>

</HTML>

</TEXT>
</DOCUMENT>
